Last Thursday, President-elect Donald Trump named Robert F. Kennedy Jr. as his pick to run the Department of Health and Human Services (HHS) when he returns to the White House. Kennedy has been vocal about his belief that the U.S. should ban pharmaceutical advertising on TV. Unlike the rest of the world, direct-to-consumer pharma advertising is only allowed in the U.S. and New Zealand.
In the U.S., pharmaceutical advertising is big business — the industry was reportedly the second largest advertiser by industry as of 2023 and Kennedy’s potential appointment has left a lot of lingering questions for marketers, as six of them told Digiday.
This is a member-exclusive article from Digiday. Continue reading it on digiday.com and subscribe to continue reading content like this.
The original post is at Marketing Archives – Digiday
Leave a Reply